2023 Q3 Form 10-Q Financial Statement

#000166357723000383 Filed on August 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q4
Revenue $22.13M $21.60M $28.26M
YoY Change 15.7%
Cost Of Revenue $14.13M $13.66M $18.62M
YoY Change 13.24%
Gross Profit $7.995M $7.940M $9.640M
YoY Change 20.32%
Gross Profit Margin 36.13% 36.75% 34.11%
Selling, General & Admin $4.307M $2.609M $4.124M
YoY Change 14.65% 13118.46% 5189.97%
% of Gross Profit 53.87% 32.85% 42.78%
Research & Development $14.22K
YoY Change -75.7%
% of Gross Profit 0.18%
Depreciation & Amortization $701.1K $653.0K $171.0K
YoY Change 24.05% 15.58%
% of Gross Profit 8.77% 8.22% 1.77%
Operating Expenses $5.008M $3.330M $4.124M
YoY Change 32.0% 3572.7% 2721.38%
Operating Profit $2.987M $4.610M $5.516M
YoY Change 4.77% -5185.18% -3873.69%
Interest Expense -$1.819M -$1.010M -$3.023M
YoY Change 346.03% -104059.16% 269066.16%
% of Operating Profit -60.89% -21.92% -54.8%
Other Income/Expense, Net $40.20K -$1.757M -$3.213M
YoY Change -109.57% 422.88% 286022.71%
Pretax Income $1.859M $2.853M
YoY Change
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $1.859M $2.853M $2.566M
YoY Change -23.53% 1062.24% -1841.93%
Net Earnings / Revenue 8.4% 13.21% 9.08%
Basic Earnings Per Share $0.02 -$0.01
Diluted Earnings Per Share $0.02 $0.03 $0.00
COMMON SHARES
Basic Shares Outstanding 114.9M shares 114.4M shares 102.9M shares
Diluted Shares Outstanding 118.6M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.758M $3.211M
YoY Change
Cash & Equivalents $1.255M $1.708M $1.313M
Short-Term Investments $1.503M $1.503M
Other Short-Term Assets $7.284M $4.944M $110.3M
YoY Change 61960212.36%
Inventory $1.437M $1.536M $1.203M
Prepaid Expenses $7.540M
Receivables $72.69M $60.41M $37.84M
Other Receivables $0.00 $0.00
Total Short-Term Assets $127.6M $116.7M $111.6M
YoY Change 240.81% 498285.0% 704591.05%
LONG-TERM ASSETS
Property, Plant & Equipment $32.23M $32.13M
YoY Change
Goodwill $56.39M $56.39M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $88.52M $89.09M
YoY Change 42264.83%
Total Long-Term Assets $88.61M $88.52M $89.09M
YoY Change 8761.37% 42264.83%
TOTAL ASSETS
Total Short-Term Assets $127.6M $116.7M $111.6M
Total Long-Term Assets $88.61M $88.52M $89.09M
Total Assets $216.2M $205.2M $200.7M
YoY Change 462.42% 876348.88% 88650.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $48.99M $41.01M $43.34M
YoY Change
Accrued Expenses $1.207M $2.290M $1.206M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $24.09M $18.91M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $150.3M $143.6M $144.7M
YoY Change 352.28% 118975.15% 24211.4%
LONG-TERM LIABILITIES
Long-Term Debt $13.11M $12.83M
YoY Change
Other Long-Term Liabilities $1.938M $1.938M $28.03M
YoY Change
Total Long-Term Liabilities $27.53M $28.35M $29.13M
YoY Change 2403.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $150.3M $143.6M $144.7M
Total Long-Term Liabilities $27.53M $28.35M $29.13M
Total Liabilities $177.8M $172.0M $173.8M
YoY Change 417.99% 142476.43% 29105.85%
SHAREHOLDERS EQUITY
Retained Earnings -$5.761M -$7.455M -$9.438M
YoY Change -47.56% -41.25% -26.05%
Common Stock $126.9K $114.6K $102.9K
YoY Change 23.33% 13.57% 8.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $38.41M $33.20M $3.235M
YoY Change
Total Liabilities & Shareholders Equity $216.2M $205.2M $200.7M
YoY Change 462.42% 876348.88% 88650.8%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q4
OPERATING ACTIVITIES
Net Income $1.859M $2.853M $2.566M
YoY Change -23.53% 1062.24% -1841.93%
Depreciation, Depletion And Amortization $701.1K $653.0K $171.0K
YoY Change 24.05% 15.58%
Cash From Operating Activities $2.106M $1.824M
YoY Change 165.49% -1399.94%
INVESTING ACTIVITIES
Capital Expenditures $798.7K -$625.3K
YoY Change 213.23%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$798.7K $625.3K
YoY Change 213.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$1.760M -$1.971M
YoY Change 261.22% -1517.29%
NET CHANGE
Cash From Operating Activities $2.106M $1.824M
Cash From Investing Activities -$798.7K $625.3K
Cash From Financing Activities -$1.760M -$1.971M
Net Change In Cash -$453.2K $477.9K
YoY Change -991.24% -39498.85%
FREE CASH FLOW
Cash From Operating Activities $2.106M $1.824M
Capital Expenditures $798.7K -$625.3K
Free Cash Flow $1.307M $2.449M
YoY Change 142.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001393781
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2022Q2 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
usd
us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
usd
CY2022Q2 QIND Stock Issued For Services
StockIssuedForServices
usd
QIND Stock Issued For Services
StockIssuedForServices
usd
CY2023Q2 us-gaap Entertainment License Agreement For Program Material Not In Film Group Impairment
EntertainmentLicenseAgreementForProgramMaterialNotInFilmGroupImpairment
usd
CY2022Q2 us-gaap Entertainment License Agreement For Program Material Not In Film Group Impairment
EntertainmentLicenseAgreementForProgramMaterialNotInFilmGroupImpairment
usd
us-gaap Entertainment License Agreement For Program Material Not In Film Group Impairment
EntertainmentLicenseAgreementForProgramMaterialNotInFilmGroupImpairment
usd
CY2023Q2 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
usd
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
usd
CY2023Q2 us-gaap Other Income
OtherIncome
usd
us-gaap Other Income
OtherIncome
usd
CY2023Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2023Q1 QIND Receivable With Imputed Interest Value
ReceivableWithImputedInterestValue
usd
CY2023Q2 QIND Receivable With Imputed Interest Value
ReceivableWithImputedInterestValue
usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2022Q2 QIND Stock Issued During Period Value Issued For Services2
StockIssuedDuringPeriodValueIssuedForServices2
usd
CY2023Q2 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
usd
CY2023Q2 QIND Settlement Of Debt
SettlementOfDebt
usd
CY2022Q2 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q2 us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
usd
CY2022Q2 us-gaap Proceeds From Loans
ProceedsFromLoans
usd
CY2023Q2 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2022Q2 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2023Q2 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
usd
CY2022Q2 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
usd
CY2023Q2 QIND Loss On License Agreement
LossOnLicenseAgreement
usd
CY2023Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
usd
CY2022Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
usd
CY2023Q2 us-gaap Noninterest Income
NoninterestIncome
usd
CY2022Q2 us-gaap Noninterest Income
NoninterestIncome
usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
usd
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2022Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2023Q2 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56239
dei Entity Registrant Name
EntityRegistrantName
Quality Industrial Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
35-2675388
dei Entity Address Address Line1
EntityAddressAddressLine1
315 Montgomery Street
dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94104
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
706-0806
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
114876965 shares
CY2023Q2 us-gaap Cash
Cash
1707801 usd
CY2022Q4 us-gaap Cash
Cash
1312565 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
60408873 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
37835611 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
1536283 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1202674 usd
CY2023Q2 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
39974415 usd
CY2022Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
57433535 usd
CY2023Q2 us-gaap Deposits
Deposits
1503279 usd
CY2022Q4 us-gaap Deposits
Deposits
1503279 usd
CY2023Q2 us-gaap Advance Payments Netted Against Claim Receivable
AdvancePaymentsNettedAgainstClaimReceivable
6612608 usd
CY2022Q4 us-gaap Advance Payments Netted Against Claim Receivable
AdvancePaymentsNettedAgainstClaimReceivable
7539940 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
4943622 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4774317 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
116686881 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
111601921 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1290081 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1365585 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
1667509 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1884569 usd
CY2023Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
118193 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
156370 usd
CY2023Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
17146631 usd
CY2022Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
17390067 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
11906654 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
11906654 usd
CY2023Q2 us-gaap Goodwill Gross
GoodwillGross
56387027 usd
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
56387027 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
88516095 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
89090272 usd
CY2023Q2 us-gaap Assets
Assets
205202976 usd
CY2022Q4 us-gaap Assets
Assets
200692193 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
43299321 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
44551407 usd
CY2023Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
18911641 usd
CY2022Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
18220315 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
81436536 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
81914399 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
143647498 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
144686121 usd
CY2023Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
2070000 usd
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1100000 usd
CY2023Q2 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
10761062 usd
CY2022Q4 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
12378098 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
13581728 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13696729 usd
CY2023Q2 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
1938218 usd
CY2022Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
1953853 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
28351008 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
29128680 usd
CY2023Q2 us-gaap Liabilities
Liabilities
171998506 usd
CY2022Q4 us-gaap Liabilities
Liabilities
173814801 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
114576965 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114576965 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
102883709 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
102883709 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
114579 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
102886 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13607017 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
12174975 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7454567 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9193862 usd
CY2023Q2 us-gaap Minority Interest
MinorityInterest
26937441 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
23793393 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
33204470 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
26877392 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
205202976 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
200692193 usd
CY2023Q2 us-gaap Revenues
Revenues
21601906 usd
CY2022Q2 us-gaap Revenues
Revenues
18216000 usd
us-gaap Revenues
Revenues
39759756 usd
us-gaap Revenues
Revenues
18216000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
13662355 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
12829000 usd
us-gaap Cost Of Revenue
CostOfRevenue
26367174 usd
us-gaap Cost Of Revenue
CostOfRevenue
12829000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
7939550 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
5378000 usd
us-gaap Gross Profit
GrossProfit
13392581 usd
us-gaap Gross Profit
GrossProfit
5378000 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
210843 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
70922 usd
us-gaap Professional Fees
ProfessionalFees
271247 usd
us-gaap Professional Fees
ProfessionalFees
217839 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2397684 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3297934 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4769690 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3335445 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
721000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
721000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
3329527 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
3368856 usd
us-gaap Operating Expenses
OperatingExpenses
5760937 usd
us-gaap Operating Expenses
OperatingExpenses
3553284 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
4610023 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2018144 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
7631644 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1833716 usd
CY2023Q2 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
25715 usd
us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
45238 usd
CY2023Q2 QIND Stock Issued For Services
StockIssuedForServices
721192 usd
QIND Stock Issued For Services
StockIssuedForServices
721192 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
-1010483 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
-408772 usd
us-gaap Interest Expense
InterestExpense
-1981871 usd
us-gaap Interest Expense
InterestExpense
409784 usd
us-gaap Entertainment License Agreement For Program Material Not In Film Group Impairment
EntertainmentLicenseAgreementForProgramMaterialNotInFilmGroupImpairment
-104550 usd
CY2023Q2 us-gaap Other Expenses
OtherExpenses
-1757390 usd
CY2022Q2 us-gaap Other Expenses
OtherExpenses
-408772 usd
us-gaap Other Expenses
OtherExpenses
-2748301 usd
us-gaap Other Expenses
OtherExpenses
-514334 usd
CY2022Q2 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
337071 usd
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
457071 usd
CY2022Q2 us-gaap Other Income
OtherIncome
337071 usd
us-gaap Other Income
OtherIncome
457071 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2852633 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
1946453 usd
us-gaap Net Income Loss
NetIncomeLoss
4883343 usd
us-gaap Net Income Loss
NetIncomeLoss
1776453 usd
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
110222564 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100621953 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106573410 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
98669372 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
26877392 usd
CY2023Q1 QIND Net Income Loss Inludes Other Amounts
NetIncomeLossInludesOtherAmounts
2030710 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
28908102 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
722735 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
721000 usd
CY2023Q2 QIND Net Income Loss Inludes Other Amounts
NetIncomeLossInludesOtherAmounts
2852633 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
33204470 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-369007 usd
CY2022Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
57824 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
104550 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-169990 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-375878 usd
CY2022Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
38742 usd
CY2022Q2 QIND Receivable With Imputed Interest Value
ReceivableWithImputedInterestValue
753 usd
CY2022Q2 QIND Receivable With Imputed Interest Reclassed To Accrued Interest Value
ReceivableWithImputedInterestReclassedToAccruedInterestValue
-6283 usd
CY2022Q2 QIND Net Income Loss52 Percent
NetIncomeLoss52Percent
1129963 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-787297 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
2852633 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
1776453 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
721000 usd
CY2023Q2 QIND Stock Issued During Period Value Issued For Services2
StockIssuedDuringPeriodValueIssuedForServices2
721192 usd
CY2023Q2 us-gaap Depreciation
Depreciation
652961 usd
CY2022Q2 us-gaap Depreciation
Depreciation
564958 usd
CY2022Q2 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
104550 usd
CY2022Q2 QIND Settlement Of Debt
SettlementOfDebt
457071 usd
CY2023Q2 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
1010483 usd
CY2022Q2 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
-409784 usd
CY2023Q2 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-5966149 usd
CY2022Q2 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-18583454 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1831451 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
16040499 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1823571 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-140281 usd
CY2023Q2 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
625337 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
625337 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
770000 usd
CY2023Q2 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
1010483 usd
CY2022Q2 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
-409784 usd
CY2023Q2 us-gaap Proceeds From Loans
ProceedsFromLoans
-1732100 usd
CY2022Q2 QIND Loss On License Agreement
LossOnLicenseAgreement
-104550 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1583 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
196331 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1971000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
139068 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
477908 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1213 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1229893 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15659 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1707801 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14446 usd
CY2022Q2 QIND Control Block Shares Transferred Shares
ControlBlockSharesTransferredShares
77669078 shares
CY2022Q2 QIND Control Block Shares Transferred Value
ControlBlockSharesTransferredValue
500000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_z4YOl1syTwDf" style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b><i>Use of estimates</i></b></p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in">A critical accounting estimate is an estimate that: (i) is made in accordance with generally accepted accounting principles, (ii) involves a significant level of estimation uncertainty and (iii) has had or is reasonably likely to have a material impact on the Company’s financial condition or results of operations.</p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The Company’s Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (U.S. GAAP). The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect reported amounts and related disclosures. On an ongoing basis, management evaluates and updates its estimates. Management employs judgment in making its estimates but they are based on historical experience and currently available information and various other assumptions that the Company believes to be reasonable under the circumstances. The results of these estimates form the basis for making judgments about the carrying values of assets and liabilities that are not readily available from other sources. Actual results could differ from those estimates. Management believes that its judgment is applied consistently and produces financial information that fairly depicts the results of operations for all periods presented.</p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">Significant estimates include estimates used to review the Company’s, impairments and estimations of long-lived assets, revenue recognition of Contract based revenue, allowances for uncollectible accounts, and the valuations of non-cash capital stock issuances. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</span></p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white"> </span></p>
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2023Q2 QIND Net Income Loss Numerator
NetIncomeLossNumerator
2852633 usd
CY2022Q2 QIND Net Income Loss Numerator
NetIncomeLossNumerator
1946443 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2852633 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1946443 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
110222564 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100621953 shares
CY2023Q2 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
110222564 usd
CY2022Q2 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
100621953 usd
CY2023Q2 us-gaap Cash
Cash
1707801 usd
CY2022Q4 us-gaap Cash
Cash
1312565 usd
CY2023Q2 QIND Retention Receivable
RetentionReceivable
2590611 usd
CY2022Q4 QIND Retention Receivable
RetentionReceivable
2800611 usd
CY2023Q2 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
2072077 usd
CY2022Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
1794218 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
70000 usd
CY2023Q2 us-gaap Other Restricted Assets Current
OtherRestrictedAssetsCurrent
210934 usd
CY2022Q4 us-gaap Other Restricted Assets Current
OtherRestrictedAssetsCurrent
179488 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
4943622 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4774317 usd
CY2023Q2 us-gaap Accrued Rent Current
AccruedRentCurrent
835943 usd
CY2022Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
836382 usd
CY2023Q2 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
77093 usd
CY2022Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
31855 usd
CY2023Q2 QIND Payable Related Party Current
PayableRelatedPartyCurrent
80500000 usd
CY2022Q4 QIND Payable Related Party Current
PayableRelatedPartyCurrent
81000000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
23500 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
46162 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
81436536 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
81914399 usd
CY2023Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
18911641 usd
CY2023Q2 us-gaap Asset Acquisition Contingent Consideration Liability
AssetAcquisitionContingentConsiderationLiability
45000000 usd
CY2023Q2 QIND Payable Related Party Current
PayableRelatedPartyCurrent
80500000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
41009707 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
43344990 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2289614 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1206417 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
43299321 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
44551407 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
28351008 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
29128680 usd
CY2023Q2 us-gaap Asset Acquisition Contingent Consideration Liability
AssetAcquisitionContingentConsiderationLiability
45000000 usd
CY2023Q2 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
10761062 usd
CY2023Q2 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
1938218 usd
CY2022Q4 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
1953853 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1938218 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1953853 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
114576965 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114576965 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
102883709 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
102883709 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
1374114 usd
CY2022Q2 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
1351700 usd
CY2023Q2 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
147300 usd
CY2022Q2 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
185000 usd
CY2023Q2 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
55238 usd
CY2022Q2 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
38900 usd
CY2023Q2 us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
9206 usd
CY2022Q2 us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
8500 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Reclassifications From Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationReclassificationsFromPropertyPlantAndEquipment1
652961 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Reclassifications From Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationReclassificationsFromPropertyPlantAndEquipment1
564958 usd
CY2023Q2 us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
18413 usd
CY2022Q2 us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
15000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14220 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
58516 usd
CY2023Q2 us-gaap Utilities Operating Expense Maintenance
UtilitiesOperatingExpenseMaintenance
11772 usd
CY2022Q2 us-gaap Utilities Operating Expense Maintenance
UtilitiesOperatingExpenseMaintenance
11857 usd
CY2023Q2 us-gaap Other General Expense
OtherGeneralExpense
114460 usd
CY2022Q2 us-gaap Other General Expense
OtherGeneralExpense
1063503 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2397684 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3297934 usd
CY2022Q2 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
337071 usd
CY2022Q2 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
337071 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
337071 usd
CY2022Q2 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
300000 usd
CY2022Q2 us-gaap Interest Expense Other Long Term Debt
InterestExpenseOtherLongTermDebt
41 usd

Files In Submission

Name View Source Status
0001663577-23-000383-index-headers.html Edgar Link pending
0001663577-23-000383-index.html Edgar Link pending
0001663577-23-000383.txt Edgar Link pending
0001663577-23-000383-xbrl.zip Edgar Link pending
ex10_10.htm Edgar Link pending
ex10_3.htm Edgar Link pending
ex10_4.htm Edgar Link pending
ex10_5.htm Edgar Link pending
ex10_6.htm Edgar Link pending
ex10_7.htm Edgar Link pending
ex10_8.htm Edgar Link pending
ex10_9.htm Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qind-20230630.xsd Edgar Link pending
qind10q_063023.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
qind-20230630_def.xml Edgar Link unprocessable
qind-20230630_cal.xml Edgar Link unprocessable
qind-20230630_pre.xml Edgar Link unprocessable
qind-20230630_lab.xml Edgar Link unprocessable
qind10q_063023_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable